Endo International plc, et al.
Case Number:
7:22-bk-22549
Court:
Nature of Suit:
Firms
- Akin Gump
- Alston & Bird
- ArentFox Schiff
- ASK LLP
- Barton LLP
- Beck Chaet
- Bielli & Klauder
- Binder & Schwartz
- Blank Rome
- Bond Schoeneck
- Brown & Connery
- Brown Rudnick
- Carter Ledyard
- Chiesa Shahinian
- Chipman Brown
- Cohen Weiss
- Connell Foley
- Cooley LLP
- Covington & Burling
- Cullen & Dykman
- Davidson Bowie
- Davidson Fink
- Davis Polk
- Dickie McCamey
- Duane Morris
- Fishman Haygood
- Fleischer Fleischer
- Foley & Lardner
- Foran Glennon
- Fox Rothschild
- FrankGecker
- Frejka PLLC
- Freshfields
- Gibson Dunn
- Glenn Agre
- Godfrey & Kahn
- Goldman Ismail
- Haynes & Boone
- Herzfeld Suetholz
- Hodgson Russ
- Hunton Andrews
- Husch Blackwell
- Jenner & Block
- Jones Day
- Katten Muchin
- Kelley Drye
- Kelly & Brennan
- Kirkland & Ellis
- Klehr Harrison
- Klestadt Winters
- K&L Gates
- Kline & Specter
- Kohner Mann
- Kramer Levin
- Kurzman Eisenberg
- Latham & Watkins
- Lemery Greisler
- Levenfeld Pearlstein
- Linebarger Goggan
- Locke Lord
- Masuda Funai
- Mayer Brown
- McCarter & English
- McElroy Deutsch
- McGrail & Bensinger
- Miller Nash LLP
- Nelson Mullins
- Nixon Peabody
- Norton Rose
- Obermayer Rebmann
- O'Melveny & Myers
- Orrick Herrington
- Paul Weiss
- Perkins Coie
- Phillips Lytle
- Pillsbury Winthrop
- Porzio Bromberg
- Potter Anderson
- Pullman & Comley
- Robinson & Cole
- Ross Smith & Binford
- Rubin LLC
- Saul Ewing
- Schiller Knapp
- Seward & Kissel
- Shafferman & Feldman
- Shipman & Goodwin
- Sills Cummis
- Simpson Thacher & Bartlett LLP
- Skadden Arps
- Squire Patton
- Stark & Stark
- Stevens & Lee
- Stranch Jennings
- Stutzman Bromberg
- Taft Stettinius
- Tarter Krinsky
- Togut Segal
- Troutman Pepper
- Tucker Arensberg
- Wachtell Lipton
- Warner Norcross
- Weltman Weinberg
- White and Williams
- White & Case
- Willkie Farr
- WilmerHale
- Young Conaway
Companies
- AbbVie Inc.
- Ahold Delhaize
- AIS Portfolio Services LLC
- Altaris Capital Partners LLC
- Alvarez & Marsal Holdings LLC
- American Federation of State County & Municipal Employees
- Amneal Pharmaceuticals Inc.
- Anchen Pharmaceuticals Inc.
- Aspen Insurance Holdings Ltd.
- AstraZeneca PLC
- Auxilium Pharmaceuticals, Inc.
- Berkeley Research Group LLC
- Cardinal Health Inc.
- Cencora Inc.
- Collegium Pharmaceutical Inc.
- Computershare Ltd.
- Consolidated Edison Inc.
- Constellation Energy Corp.
- Cornerstone Research Inc.
- CVS Health Corp.
- Dayforce Inc.
- DTE Energy Co.
- Ducera Partners LLC
- Dundon Advisers LLC
- Endo International PLC
- Ernst & Young LLP
- Evidera
- Evoqua Water Technologies LLC
- Express Scripts Holding Co.
- Ford Motor Co.
- Glenmark Pharmaceuticals Ltd.
- Grant Thornton LLP
- Grunenthal Group
- Henry Schein Inc.
- Jefferies Financial Group Inc.
- Johnson Controls International PLC
- Johnson & Johnson
- KPMG International
- Lazard Ltd.
- Lexington Insurance Co.
- Liberty Mutual Insurance Group
- Life Technologies Corporation
- McKesson Corp.
- Medco Health Solutions Inc.
- Merck & Co. Inc.
- Novitium Pharma LLC
- Optum Inc.
- OptumRx Inc.
- Oracle Corp.
- Par Pharmaceutical Cos. Inc.
- Patheon Inc.
- PCI Pharma Services
- PECO Energy Co.
- Pfizer Inc.
- PricewaterhouseCoopers LLP
- Province LLC
- SAP AG
- SAS Institute Inc.
- Teikoku Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- The Hartford Financial Services Group Inc.
- Thermo Fisher Scientific Inc.
- Toyota Industries Commercial Finance Inc.
- UMB Financial Corp.
- United BioSource Corp.
- United Steelworkers
- U.S. Bancorp
- Walmart Inc.
- Wilmington Trust Corp.
Government Agencies
- Missouri Department of Revenue
- National Labor Relations Board
- Rochester City School District
- State of Indiana
Sectors & Industries:
-
August 19, 2024
TPG Dumped Opioid Co. On 'Unsuspecting' Endo, Suit Says
After pushing Par Pharmaceutical to grow its market share in generic opioids and disregard federal requirements to report suspicious orders, TPG Capital saw other opioid manufacturers being inundated with litigation and sold Par to "an unsuspecting" Endo International PLC, according to a lawsuit filed in New York bankruptcy court.
-
August 16, 2024
McKinsey Drove Opioid Sale Scheme, Endo Ch. 11 Trust Says
Consulting giant McKinsey & Co. should pay at least $1.5 billion to cover costs pharmaceutical developer Endo International racked up defending against claims that it helped drive the opioid crisis, an unsecured creditors' trustee has said, telling a New York bankruptcy judge the consultant's marketing and sales advice lit a "ticking time bomb" that sent Endo into Chapter 11.
-
April 22, 2024
Endo Creditor Trust Asks For $50M In Litigation Financing
The committee of unsecured creditors in the Chapter 11 case of pharmaceutical company Endo International asked a New York bankruptcy judge Monday for permission to enter into a $50 million secondary financing facility to help the creditor trust created under the company's bankruptcy plan pursue litigation and settlements of potential claims.
-
March 20, 2024
Endo Plan To Trim $5B In Debt Confirmed By NY Judge
Drugmaker Endo International got a New York bankruptcy judge's approval for its Chapter 11 plan that aims to cut more than $5 billion in debt and hand over ownership to its lenders, roughly a month after it finalized a $465 million deal to resolve criminal and civil opioid claims.
-
February 29, 2024
Bankrupt Endo To Pay $465M To Resolve Opioid Claims
Drugmaker Endo International has agreed to pay as much as $465 million to resolve criminal and civil claims stemming from its sale and marketing of a powerful opioid, and will turn over its assets to a group of secured lenders who will operate the company under a new corporate structure.
-
February 02, 2024
Drugmaker Endo Wants To Extend Opioid Suit Pause
Endo has asked a New York bankruptcy judge to pause the opioid litigation leveled against it for five more months, asserting that the pharmaceutical company made "wide-ranging progress" in its Chapter 11 case and expects to have a reorganization plan confirmed by March.
-
September 21, 2023
Skadden Nabs $19M Fee For 4 Months' Work On Endo Ch. 11
Skadden Arps Slate Meagher & Flom LLP was cleared Thursday by a New York judge to be paid over $19 million for its work from January to April 2023 on the Chapter 11 bankruptcy of pharmaceutical company Endo International PLC.
-
July 20, 2023
Endo International Wins More Support For $6B Ch. 11 Sale
Bankrupt pharmaceutical company Endo International PLC told a New York judge Thursday that it has resolved objections from key stakeholders in its Chapter 11 case and garnered increased support for a $6 billion sale of its assets to a group of debtholders.
-
July 19, 2023
Endo Pitches Deal With Distributors Over Ch. 11 Sale Plan
Bankrupt pharmaceutical company Endo International asked a New York bankruptcy court Tuesday to approve a settlement with distributors, manufacturers and pharmacies over indemnification of claims in opioid litigation that should remove an obstacle blocking the sale of Endo's assets.
-
April 12, 2023
Endo Gets OK For $27M Deal With Novavax In Contract Fight
A New York bankruptcy judge on Wednesday gave Endo International permission to settle a contract dispute with COVID-19 vaccine maker Novavax for $27 million after the pharmaceutical company said Novavax may be heading for bankruptcy itself.